In this article, we discuss the 5 best dividend stocks to buy according to billionaire Richard Chilton. If you want to read our detailed analysis of Chilton’s history and hedge fund performance, go directly to the 10 Best Dividend Stocks to Buy According to Billionaire Richard Chilton.
5. Pfizer Inc. (NYSE: PFE)
Chilton’s Stake Value: $212,000
Percentage of Richard Chilton’s 13F Portfolio: 0.001%
Dividend Yield: 3.96%
No. of Hedge Fund Holders: 63
Pfizer Inc. (NYSE: PFE) is a global pharmaceutical company specializing in the discovery, development, production, marketing, distribution, and sale of biopharmaceutical products around the world.
The company recently announced strong results for Q1 2021, with $14.6 billion in revenue representing a whopping 42% growth from the same period in 2020. This revenue does not include the $3.5 billion sales from BNT162b2.
In anticipation of strong contribution from the solid performance of BNT162b2 as well as the strong performance of the business in general, the company has raised its guidance ranges for revenue, adjusted cost of sales, adjusted R&D expenses, and adjusted diluted EPS.
Pfizer Inc. (NYSE: PFE) has also requested the Medicines and Healthcare products Regulatory Agency (MHRA), the U.K.’s medical regulator, to approve its COVID-19 vaccine for use in young teenagers. The company has since submitted efficacy data for the jab that targets 12 to 15-year-olds. The vaccine is expected to be approved well before the end of July, thanks to MHRA’s fast-track review process.
4. AbbVie Inc. (NYSE: ABBV)
Chilton’s Stake Value: $798,000
Percentage of Richard Chilton’s 13F Portfolio: 0.02%
Dividend Yield: 4.53%
No. of Hedge Fund Holders: 83
AbbVie Inc. (NYSE: ABBV) is a specialist in discovering, developing, producing, and selling pharmaceuticals worldwide. In its financial results for Q1 2021, the company reported net revenues of $13.010 billion on a GAAP Basis, representing a 51.0% increase compared to a reported basis. Adjusted net revues during the quarter amounted to $13 billion.
Allergan Aesthetics, a subsidiary of AbbVie Inc. (NYSE: ABBV), has signed an agreement to acquire Soliton and its Rapid Acoustic Pulse device called RESONICTM, which recently received clearance from the U.S. Food and Drug Administration (FDA).
RESONICTM is a non-invasive treatment for short-term improvement in the appearance of cellulite. The deal is expected to bolster the Allergan Aesthetics’ Body Contouring treatment portfolio that already has a number of products like CoolSculpting® Elite.
The Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted a positive opinion for AbbVie Inc. (NYSE: ABBV)’s Venclyxto (venetoclax), which is used together with hypomethylating agents in the treatment of newly diagnosed acute myeloid leukemia (AML) in adult patients who cannot be subjected to intensive chemotherapy. The European Commission is set to give the final determination on Venclyxto combination therapy in the first half of 2021. AbbVie and Roche are developing Venetoclax.
3. Exxon Mobil Corporation (NYSE: XOM)
Chilton’s Stake Value: $297,000
Percentage of Richard Chilton’s 13F Portfolio: 0.001%
Dividend Yield: 5.74%
No. of Hedge Fund Holders: 63
Exxon Mobil Corporation (NYSE: XOM) is a U.S. company that deals with the exploration and production of crude oil products in the United States and worldwide. It operates through Upstream, Downstream, and Chemical segments. The stock ranks 3rd in the list of best dividend stocks to buy based on Richard Chilton’s Q1’2021 portfolio.
The Iraq government recently requested to buy 32.7% of the company’s stake in West Qurna 1, one of the largest oilfields in Iraq. The company is selling its stake in the oil fields in order to reduce the massive debt accumulated in 2020.
A consortium made up of Exxon Mobil Corporation (NYSE: XOM), Royal Dutch Shell, Air Liquide, and Air Products has been granted subsidies amounting to $2.4 billion by the Dutch government to set up what could become the largest carbon capture and storage projects in the world. The group requested the subsidies to put up the project expected to capture carbon produced by refineries and factories in the Rotterdam port area. The captured CO2 will be stored in empty Dutch gas fields in the North Sea.
Exxon Mobil Corporation (NYSE: XOM) announced $2.7 billion, or $0.64 per share, earnings for Q1 2021 compared to a loss of $610 million reported in Q1 2020. The company’s capital and exploration expenditures during the quarter amounted to $3.1 billion, which is a drop of $4 billion from Q1 2020. The Q1 2021 results included unfavorable identified items of $31 million, or $0.01 per share, assuming dilution.
Harding Loevner, in its Q1 2021 investor letter, mentioned Exxon Mobil Corporation (NYSE: XOM). Here is what Harding Loevner has to say about Exxon Mobil Corporation in its letter:
“We felt that our remaining energy holding, ExxonMobil, with its stronger balance sheet, was in a better position to ride out the cyclical slump in oil demand and even perhaps take advantage of it by investing counter-cyclically. While ExxonMobil does plan to increase capital expenditure, we’ve been disappointed in its regrettable failure to address ongoing emission trends, which reflects poorly on management’s foresight. As a result, we sold our ExxonMobil holdings.”
2. Blackstone Mortgage Trust, Inc. (NYSE: BXMT)
Chilton’s Stake Value: $1,690,000
Percentage of Richard Chilton’s 13F Portfolio: 0.04%
Dividend Yield: 8.13%
No. of Hedge Fund Holders:
Blackstone Mortgage Trust, Inc. (NYSE: BXMT) has reported its results for Q1 2021, with CEO Stephen D. Plavin saying the results demonstrated the strong momentum the company has put in place it drives its revenue. The company closed $1.7 billion in new loans during the quarter and grew its loan portfolio by around $700 million. Plavin says the company will continue to leverage its strong balance sheet to position the company to capture the next wave of investment opportunities.
Blackstone Mortgage Trust, Inc. (NYSE: BXMT) has completed the $3.4 billion acquisition of a best‐in‐class portfolio of lab office buildings from a Brookfield Asset Management real estate fund. Together, the buildings have a cumulative space of 2.3 million square feet.
1. Enterprise Products Partners L.P. (NYSE: EPD)
Chilton’s Stake Value: $2,119,000
Percentage of Richard Chilton’s 13F Portfolio: 0.05%
Dividend Yield: 7.78%
No. of Hedge Fund Holders: 30
Enterprise Products Partners L.P. (NYSE: EPD) specializes in the provision of midstream energy services to producers and consumers of energy products like crude oil, natural gas, natural gas liquids (NGLs), refined products, and petrochemicals.
Enterprise Products Partners L.P. (NYSE: EPD) has released its financial results for Q1 2021 with net income from common unitholders amounting to $1.3 billion or $0.61 per share. This is a drop from the $1.4 billion net income reported in the same period in 2020. The reduction in net income is attributed to $66 million, or $0.03 per fully diluted unit, in non-cash asset impairment charges.
You can also take a peek at 14 Best European Dividend Stocks To Buy and 15 Very High Yield Dividend Stocks Worth Checking Out.
